Novacyt S.A. (EPA:ALNOV)
France · Delayed Price · Currency is EUR 0.4335
+0.0005 (0.12%)
At close: Nov 28, 2025
Novacyt Market Cap
Novacyt has a market cap or net worth of €30.57 million as of November 28, 2025. Its market cap has decreased by -25.16% in one year.
Market Cap
30.57M
Enterprise Value
15.67M
Revenue
22.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.43
Market Cap Chart
Since October 12, 2012, Novacyt's market cap has increased from 23.55M to 30.57M, an increase of 29.77%. That is a compound annual growth rate of 2.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 30.57M | -28.02% |
| Dec 31, 2024 | 42.47M | -15.60% |
| Dec 29, 2023 | 50.32M | -42.02% |
| Dec 30, 2022 | 86.78M | -71.94% |
| Dec 31, 2021 | 309.30M | -55.31% |
| Dec 31, 2020 | 692.08M | 6,955.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 142.36B |
| Sanofi | 104.35B |
| Sartorius Stedim Biotech | 20.17B |
| bioMérieux | 12.74B |
| Eurofins Scientific SE | 10.39B |
| Ipsen | 10.21B |
| ABIVAX Société Anonyme | 8.16B |
| Virbac | 3.08B |